245.86

0.62% 1.51

West Pharmaceutical Services Inc (WST)

Overview News Price History Option Chain Financials Why WST Down? Discussions Forecast Stock Split Dividend History

West Pharmaceutical Services Inc stock is traded at $245.86, with a volume of 1.08M. It is up +0.62% in the last 24 hours and down -1.24% over the past month. West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Previous Close:

$244.35

Open:

$241

24h Volume:

1.08M

Relative Volume:

1.20

Market Cap:

$17.71B

Revenue:

$2.96B

Net Income/Loss:

$487.70M

P/E Ratio:

36.83

EPS:

6.6758

Net Cash Flow:

$344.00M

1W Performance:

-3.33%

1M Performance:

-1.24%

6M Performance:

-1.94%

1Y Performance:

+5.63%

1-Day Range:

$239.75

$246.28

1-Week Range:

$239.75

$254.60

52-Week Range:

$187.43

$322.34

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name

West Pharmaceutical Services Inc

Sector

Healthcare (1105)

Industry

Medical Instruments & Supplies (58)

Phone

(610) 594-2900

Address

530 HERMAN O. WEST DRIVE, EXTON, PA

Employee

10,800

Twitter

@WestPharma

Next Earnings Date

2024-10-24

Latest SEC Filings

WST's Discussions on Twitter

Compare WST vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WST West Pharmaceutical Services Inc	245.86	17.60B	2.96B	487.70M	344.00M	6.6758
ISRG Intuitive Surgical Inc	490.16	176.39B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	167.12	48.34B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	81.33	40.22B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	252.87	37.19B	5.40B	1.49B	1.78B	10.12
MDLN Medline Inc	43.83	35.75B	28.43B	1.16B	1.26B	1.4457

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Initiated	Morgan Stanley	Equal-Weight
Sep-15-25	Initiated	Rothschild & Co Redburn	Buy
Jun-24-25	Initiated	Barclays	Equal Weight
Mar-18-25	Initiated	Evercore ISI	Outperform
Feb-14-25	Upgrade	Deutsche Bank	Hold → Buy
Jan-08-25	Initiated	Citigroup	Buy
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-12-24	Upgrade	UBS	Neutral → Buy
Feb-07-24	Upgrade	Jefferies	Hold → Buy
Jun-16-23	Upgrade	BofA Securities	Neutral → Buy
Apr-11-23	Upgrade	Stephens	Equal-Weight → Overweight
Dec-14-22	Initiated	Deutsche Bank	Hold
Nov-30-22	Initiated	UBS	Neutral
Oct-28-22	Downgrade	BofA Securities	Buy → Neutral
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Oct-14-20	Initiated	Stephens	Equal-Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Apr-24-20	Upgrade	BofA/Merrill	Underperform → Neutral
Dec-12-19	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-19	Upgrade	BofA/Merrill	Underperform → Neutral
May-01-19	Downgrade	Jefferies	Buy → Hold
Apr-23-19	Initiated	William Blair	Outperform
Apr-25-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-24-18	Initiated	Goldman	Neutral
Oct-17-17	Downgrade	BofA/Merrill	Buy → Neutral
Oct-03-17	Initiated	Stephens	Equal-Weight
Sep-15-17	Upgrade	Jefferies	Hold → Buy
Oct-28-16	Upgrade	Wells Fargo	Market Perform → Outperform
Sep-21-16	Downgrade	Wells Fargo	Outperform → Market Perform
Mar-22-16	Initiated	Wells Fargo	Outperform
May-14-10	Reiterated	UBS	Neutral
Feb-23-10	Initiated	Jefferies & Co	Buy
Dec-19-08	Initiated	UBS	Neutral

View All

West Pharmaceutical Services Inc Stock (WST) Latest News

Mar 06, 2026

West Pharma climbs 0.62% following robust Q4 results and GLP-1 momentum, securing the 501st spot with $260M in trading volume as analysts highlight a 25% price premium - Bitget

Mar 06, 2026

What is Zacks Research's Forecast for WST Q1 Earnings? - MarketBeat

Mar 06, 2026

Wearable Injectors Market Set to Witness Rapid Growth Through - openPR.com

Mar 06, 2026

Mar 05, 2026

West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar

Mar 05, 2026

Mar 04, 2026

William Blair Investment Management LLC Trims Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat

Mar 04, 2026